1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ALLARITY THERAPEUTICS INC
Allarity Therapeutics Inc XNAS: ALLR
1.14 -0.02 (-1.72%)
58,992
XNAS Volume

XNAS 05 Dec, 2025 4:30 PM (EST)

Watchlist

Portfolio

Alert



Insider Trading disclosures for Allarity Therapeutics Inc

The latest disclosure was made by Jeremy R. Graff in Allarity Therapeutics Inc where a trade of 39,494 Common Stock done was reported to US exchanges on Sept. 30, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Jeremy R. Graff See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Sep 2025 39,494 39,494 - - Common Stock
Jeremy R. Graff See Remarks Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Sep 2025 39,494 223,430 - - Restricted Stock Units
Jeremy R. Graff See Remarks Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.58 per share. 30 Sep 2025 14,613 24,881 - 1.6 23,089 Common Stock
Joseph W. Vazzano Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2025 25,000 25,000 - - Stock Options
Thomas H. Jensen CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2025 396,734 396,734 - 0 Common Stock
Jeremy Graff R. CDO Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2025 144,441 262,924 - 0 Common Stock
Laura E. Benjamin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2025 25,000 25,000 - - Stock Options
Alexander Epshinsky CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2025 29,496 85,051 - 0 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures